The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression

  • Authors:
    • Kleita Michaelidou
    • Alexandros Tzovaras
    • Ioannis Missitzis
    • Alexandros Ardavanis
    • Andreas Scorilas
  • View Affiliations

  • Published online on: March 21, 2013     https://doi.org/10.3892/ijo.2013.1860
  • Pages: 1770-1777
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer (BC) continues to affect the lives of millions of women worldwide. Several members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) subfamily are involved in tumor progression. Notably, the CEACAM subfamily harbors the already established cancer biomarker CEA, as well as other potential molecular markers. CEACAM19, a recently identified gene belonging to CEACAM subfamily, was discovered and cloned by members of our research group. The present study analyzes, quantitatively, the expression of CEACAM19 and evaluates its clinical relevance in BC. Total RNA was extracted from 143 cancerous and 89 normal adjacent breast tissue specimens. Following reverse transcription, quantitative analysis of CEACAM19 mRNA expression levels was performed via real-time PCR and the comparative Ct (2-∆∆Ct) method. CEACAM19 expression and detailed clinicopathological data were used for extensive biostatistical analyses. CEACAM19 was found to be overexpressed in breast cancer tissue specimens compared to normal tissue counterparts (p=0.013). CEACAM19 mRNA expression status was also associated with clinicopathological features indicative of aggressive behavior and poor prognosis in BC, such as high tumor grade (p=0.031) and high Ki67 proliferative index (p=0.038). A significant negative association was documented between CEACAM19 expression and tumor ER status (p=0.018) as well as patients' menopausal state (p=0.016). Our results suggest that CEACAM19 mRNA expression represents a promising, novel and clinically useful tissue biomarker for breast cancer management.
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 42 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Michaelidou K, Tzovaras A, Missitzis I, Ardavanis A and Scorilas A: The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol 42: 1770-1777, 2013
APA
Michaelidou, K., Tzovaras, A., Missitzis, I., Ardavanis, A., & Scorilas, A. (2013). The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. International Journal of Oncology, 42, 1770-1777. https://doi.org/10.3892/ijo.2013.1860
MLA
Michaelidou, K., Tzovaras, A., Missitzis, I., Ardavanis, A., Scorilas, A."The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression". International Journal of Oncology 42.5 (2013): 1770-1777.
Chicago
Michaelidou, K., Tzovaras, A., Missitzis, I., Ardavanis, A., Scorilas, A."The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression". International Journal of Oncology 42, no. 5 (2013): 1770-1777. https://doi.org/10.3892/ijo.2013.1860